A study for a 39 year old man who takes Stribild - from FDA reports


Summary

116 males aged 39 (±5) who take the same drug are studied. This is a personalized study for a 39 year old male patient who has Hiv. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Jun, 19, 2017

116 males aged 39 (±5) who take Stribild are studied.


Number of reports submitted per year:

Stribild for a 39-year old man.

Information of the patient in this study:

  • Age: 39
  • Gender: male
  • Conditions: Hiv
  • Drugs taken:
    • Stribild (cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • anaphylaxis
  • muscle aches
  • pain
  • chest pain
  • itching
  • headache
  • rashes
  • diarrhea
  • agitation
  • hyperhidrosis
1 - 6 months:
  • haemorrhage subcutaneous
  • mucosal haemorrhage
  • drug ineffective
  • rashes
  • fever
  • upper respiratory tract inflammation
  • genital herpes
  • lymphoma
  • pharyngeal inflammation
  • haemorrhage
6 - 12 months:
  • joint pain
  • muscle aches
  • rashes
  • neuralgia
  • seizures
  • gastric ulcer
  • hepatomegaly
  • rash pruritic
  • skin toxicity
  • toothaches
1 - 2 years:
n/a
2 - 5 years:
  • osteoporosis
  • osteopenia
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • diarrhea
  • adrenal suppression
  • nausea
  • nausea and vomiting
  • fatigue
  • blood creatinine increased
  • paraesthesia
  • joint pain
  • pancreatitis
  • weight increased

Top conditions involved for these people *:

  • High Blood Pressure (6 people, 5.17%)
  • Nasal Congestion (4 people, 3.45%)
  • Insomnia (3 people, 2.59%)
  • Hiv Test Positive (3 people, 2.59%)
  • Factor Viii Deficiency (3 people, 2.59%)

Top co-used drugs for these people *:

  • Truvada (8 people, 6.90%)
  • Atripla (8 people, 6.90%)
  • Isentress (4 people, 3.45%)
  • Bactrim Ds (4 people, 3.45%)
  • Egrifta (3 people, 2.59%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Stribild, Hiv

You may be interested in these reviews

More reviews for: Stribild, Hiv